Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-05-20 Polymeropoulos Mihael Hristos President and CEO Option exercise · Employee Stock Option (Right to Buy) −73,608 79,019
2019-05-17 Polymeropoulos Mihael Hristos President and CEO Option exercise +97,373 $12.55 $1.2M 1,276,343
2019-05-17 Polymeropoulos Mihael Hristos President and CEO Sale −77,225 $15.56 $1.2M 1,199,118
2019-05-17 Polymeropoulos Mihael Hristos President and CEO Option exercise · Employee Stock Option (Right to Buy) −97,373 152,627
2019-04-23 Chrousos Phaedra Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2019-03-04 Reverberi Gian Piero SVP & Chief Commercial Officer Sale −443 $19.92 $9K 167,989
2019-03-04 Polymeropoulos Mihael Hristos President and CEO Sale −38,166 $19.41 $741K 1,178,970
2019-03-04 Kelly James Patrick EVP & Chief Financial Officer Sale −8,751 $19.88 $174K 209,746
2019-03-04 Birznieks Gunther SVP, Business Development Sale −8,788 $19.89 $175K 151,251
2019-03-01 Reverberi Gian Piero SVP & Chief Commercial Officer Sale −438 $20.17 $9K 168,432
2019-03-01 Polymeropoulos Mihael Hristos President and CEO Sale −6,500 $20.22 $131K 1,217,136
2019-03-01 Kelly James Patrick EVP & Chief Financial Officer Sale −4,976 $20.15 $100K 218,497
2019-03-01 Birznieks Gunther SVP, Business Development Sale −3,741 $20.14 $75K 160,039
2019-02-27 Williams Timothy SVP & General Counsel Grant or award +30,000 60,000
2019-02-27 Williams Timothy SVP & General Counsel Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2019-02-27 Reverberi Gian Piero SVP & Chief Commercial Officer Grant or award +30,000 168,870
2019-02-27 Reverberi Gian Piero SVP & Chief Commercial Officer Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2019-02-27 Polymeropoulos Mihael Hristos President and CEO Grant or award +60,000 1,223,636
2019-02-27 Polymeropoulos Mihael Hristos President and CEO Grant or award · Employee Stock Option (Right to Buy) +140,000 140,000
2019-02-27 Kelly James Patrick EVP & Chief Financial Officer Grant or award +30,000 223,473

Page 17 of 20 · 387 trades